Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Heart Palpitation Relief With Melissa Officinalis Leaf Extract: Double Blind, Randomized, Placebo Controlled Trial of Efficacy and Safety Publisher Pubmed



Alijaniha F1 ; Naseri M2 ; Afsharypuor S3 ; Fallahi F4 ; Noorbala A5 ; Mosaddegh M6 ; Faghihzadeh S7 ; Sadrai S8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Traditional Pharmacy, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Traditional Medicine Clinical Trial Research Center, Shahed University, Tehran, Iran
  3. 3. Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Cardiology Department, Shahed University, Tehran, Iran
  5. 5. Psychosomatic Ward Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Traditional Medicine and Materia Medica Research Center (TMRC), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  7. 7. Department of Biostatistic and Epidemiology, School of Medicine, Zanjan University of Medical Science, Zanjan, Iran
  8. 8. Division of Biopharmaceutics and Pharmacokinetics, Department of Pharmaceutics, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Ethnopharmacology Published:2015


Abstract

Abstract Ethnopharmacological relevance In Traditional Iranian Medicine (TIM), Melissa officinalis L. is commonly regarded as an effective therapy for heart palpitations. Objective Heart palpitation is a common complaint that is often benign and associated with a marked distress that makes the condition difficult to treat. Herbal medicines provide an alternative to conventional drugs for treating various kinds of diseases. This study was done as a double blind randomized placebo-controlled clinical trial to evaluate the efficacy and safety of the dried extract of M. officinalis on adults suffering from benign palpitations. Materials and methods Eligible volunteers were randomly assigned as outpatients to a 14 day treatment with 500 mg twice a day of lyophilized aqueous extract of M. officinalis leaves (or placebo). Participants in the tests, physicians and researchers were blind to group assignments. Both primary and secondary outcomes were patient-reported. Primary outcomes were obtained from two measures: mean frequency of palpitation episodes per week, derived from patients' diaries, and mean intensity of palpitation estimated through Visual Analogue Scale (VAS) in a self-report questionnaire. Psychiatric symptoms (somatization, anxiety and insomnia, social dysfunction and severe depression) were evaluated as secondary outcomes by General Health Questionnaire-28 (GHQ-28), before and after intervention. Results Fifty-five volunteers out of 71 recruited study subjects completed the trial. Results showed that 14-day of treatment with lyophilized aqueous extract of M. officinalis leaves reduced frequency of palpitation episodes and significantly reduced the number of anxious patients in comparison to the placebo (P=0.0001, P=0.004 resp.). Also, M. officinalis extract showed no indication of any serious side effects. Conclusion Lyophilized aqueous extract of M. officinalis leaves may be a proper and safe herbal drug for the treatment of benign palpitations. © 2015 Elsevier Ireland Ltd. All right reserved.
Other Related Docs
14. Hepatotoxicity Effects of Medicinal Plants, New Armenian Medical Journal (2024)
18. A Narrative Review of Herbal Remedies for Managing Hirsutism, International Journal of Preventive Medicine (2024)